Relpax Dr (dual Release) Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 18 years ago on Saturday, October 1, 2005, according to the United State Patent & Trademark Office
Word Mark Relpax Dr (Dual Release)
Status Dead 606 — Abandoned - No Statement of Use Filed
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Serial Number 78222509
Status Date Saturday, October 1, 2005
Filing Date Saturday, October 1, 2005
Attorney Stacey Hallerman

Correspondent

Christopher N. Bolinger
Pfizer Inc.
#150/5/25
150 E. 42nd Street
New York NY 10017

Case File Statements

Disclaimer with Predetermined Text "Dr (Dual Release)"
Goods & Services Pharmaceutical Preparation for the Treatment of Migraines
Pseudo Mark Relpax Dr Dual Release

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Friday, March 28, 2003
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.